Cytoskeletal regulation of the L-arginine/NO pathway in pulmonary artery endothelial cells.
We investigated possible involvement of the actin cytoskeleton in the regulation of the L-arginine/nitric oxide (NO) pathway in pulmonary artery endothelial cells (PAEC). We exposed cultured PAEC to swinholide A (Swinh), which severs actin microfilaments, or jasplakinolide (Jasp), which stabilizes actin filaments and promotes actin polymerization, or both. After treatment, the state of the actin cytoskeleton, L-arginine uptake mediated by the cationic amino acid transporter-1 (CAT-1), Ca(2+)/calmodulin-dependent (endothelial) NO synthase (eNOS) activity and content, and NO production were examined. Jasp (50-100 nM, 2 h treatment) induced a reversible activation of L-[(3)H]arginine uptake by PAEC, whereas Swinh (10-50 nM) decreased L-[(3)H]arginine uptake. The two drugs could abrogate the effect of each other on L-[(3)H]arginine uptake. The effects of both drugs on L-[(3)H]arginine transport were not related to changes in expression of CAT-1 transporters. Swinh (50 nM, 2 h) and Jasp (100 nM, 2 h) did not change eNOS activities and contents in PAEC. Detection of NO in PAEC by the fluorescent probe 4,5-diaminofluorescein diacetate showed that Swinh (50 nM) decreased and Jasp (100 nM) increased NO production by PAEC. The stimulatory effect of Jasp on NO production was dependent on the availability of extracellular L-arginine. Our results indicate that the state of actin microfilaments in PAEC regulates L-arginine transport and that this regulation can affect NO production by PAEC.
Zharikov
S I
SI
Department of Medicine, University of Florida College of Medicine, Gainesville, Florida 32608-1197, USA.
Sigova
A A
AA
Chen
S
S
Bubb
M R
MR
Block
E R
ER
D000199:Actins / Q000502:physiology; D000818:Animals; D001120:Arginine / Q000378:metabolism*; D002478:Cells, Cultured; D003599:Cytoskeleton / Q000502:physiology*; D047630:Depsipeptides; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism*; D008387:Marine Toxins / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III; D010456:Peptides, Cyclic / Q000494:pharmacology; D011651:Pulmonary Artery / Q000166:cytology / Q000378:metabolism*; D013552:Swine
D000199:Actins; D047630:Depsipeptides; D008387:Marine Toxins; D010456:Peptides, Cyclic; C057531:jasplakinolide; D009569:Nitric Oxide; D001120:Arginine; C086235:swinholide A; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III